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OBJECTIVES: Previous reports have revealed that several cytokines (including platelet-derived growth factor-BB,
transforming growth factors-b1 and insulin-like growth factor-1) can enhance the rate of bone formation and
synthesis of extracellular matrix in orthopaedics or periodontology. This study aimed to determine the con-
centration of cytokines within platelet-rich fibrin microstructures and investigate whether there are differences
in the different portions of platelet-rich fibrin, which has implications for proper clinical use of platelet-rich
fibrin gel.
METHODS:Whole blood was obtained from six New Zealand rabbits (male, 7 to 39 weeks old, weight 2.7-4 kg);
it was then centrifuged for preparation of platelet-rich fibrin gels and harvest of plasma. The resultant platelet-
rich fibrin gels were used for cytokine determination, histological analyses and scanning electron microscopy.
All plasmas obtained were subject to the same cytokine determination assays for the purpose of comparison.
RESULTS: Cytokines platelet-derived growth factor-BB and transforming growth factor-b1 formed concentra-
tion gradients from high at the red blood cell end of the platelet-rich fibrin gel (p=1.88 10-5) to low at the
plasma end (p=0.19). Insulin-like growth factor-1 concentrations were similar at the red blood cell and plasma
ends. The porosities of the platelet-rich fibrin samples taken in sequence from the red blood cell end to the
plasma end were 6.5%± 4.9%, 24.8%± 7.5%, 30.3%± 8.5%, 41.4%± 12.3%, and 40.3%± 11.7%, respectively,
showing a gradual decrease in the compactness of the platelet-rich fibrin network.
CONCLUSION: Cytokine concentrations are positively associated with platelet-rich fibrin microstructure and
portion in a rabbit model. As platelet-rich fibrin is the main entity currently used in regenerative medicine,
assessing cytokine concentration and the most valuable portion of PRF gels is essential and recommended to all
physicians.
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’ INTRODUCTION
Platelet-rich fibrin (PRF) is a second generation platelet-
containing biomaterial with potential applications in wound
healing. Unlike the first generation of platelet-rich products,
such as platelet-rich plasma (PRP), PRF does not require
the addition of an anticoagulant (such as ethylenediaminete-
traacetic acid [EDTA]) during the initial drawing of blood,
nor calcium chloride nor bovine thrombin to induce poly-
merization (1,2). PRF traps platelets and platelet cytokines in
a fibrin gel. Its multitude of cytokines at concentrations
significantly higher than the baseline blood levels stimulates
autologous regeneration (3). Articular cartilage repair (4-6),
regeneration after oral and maxillofacial surgery (7-9), and
wound healing (10-12), all depend on the presence of cyto-
kines that stimulate the migration and proliferation of cells
within the affected part of the body. Quantification of the
platelet cytokines in PRF is essential to evaluating its efficacy
as a biomaterial for regenerative medicine.
The ultrastructure and fibre thickness of rabbit PRF are
similar to those of human fibrin (13). Thus, in a previous study,
to explore the potential use of PRF gel in regenerative medi-
cine, we used an experimental rabbit model to investigate the
regeneration of articular cartilage defects in the knee; this
model consisted of autologous implantation of PRF andminced
cartilage fragments into injured knees (4). Although the study
indicated that the observed healing might be due to the release
of cytokines from the autologous PRF, no qualitative or quanti-
tative evidence of platelet cytokines in the PRF was presented,
limiting the preclinical elucidation of the study and its trans-
lation to clinical treatment of articular cartilage injury.
Dohan and coworkers (14) quantified the cytokine con-
centrations in the three layers formed by centrifugation ofDOI: 10.6061/clinics/2017(02)09
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blood in a collection tube (red blood cells [RBC], PRF, and
plasma), but they considered the middle layer (i.e., the PRF gel)
to be the only potential cytokine source for clinical practice and
therefore focused on measuring the concentration of platelet
cytokines in PRF gels. In another study, it was shown that fibrin
architecture and leukocyte content influence cytokine release
from four different families of platelet concentrates, not includ-
ing PRF (15,16). The abovementioned findings inspired us to ask
whether cytokines are concentrated and evenly distributed in
PRF gel, as this is the main entity currently used in regenerative
medicine, for example, in dentistry (17,18).
In this study, we focused on PRF gel because this is
the only autologous family of platelet concentrates without
the addition of foreign reagent and able to reserve and
release cytokines in a controlled manner (19). Three plate-
let cytokines (platelet-derived growth factor-BB: PDGF-BB,
transforming growth factor-beta 1: TGF-b1 and insulin-like
growth factor 1: IGF-1) were chosen for analyses because
their biological activities during initial healing are well under-
stood (20). Although research on human cytokines quanti-
fication has been widely reported (21-25), we approached
the issue differently in this study by quantifying cytokines
obtained from districted PRF, not global PRF, in rabbits. It is
because of the unexpected discovery of an uneven distribu-
tion of cytokines in our previous study to elucidate the
potential use of PRF gel in regenerated articular cartilage
defects in rabbits’ knees. We therefore raised two questions:
first whether these cytokines are indeed concentrated in the
PRF gel rather than in plasma, and second, if so, whether
they are evenly distributed in the fibrin network of the PRF
gel. These questions led us to determine the cytokine content
of PRF and its relationship with the three-dimensional fibrin
network structure.
’ MATERIALS AND METHODS
Preparation of PRF gel and matrix
Six New Zealand rabbits (male, 7 to 39 weeks old, weight
2.7-4 kg) were used for the preparation of PRF gels. The animal
breeding practices and animal use protocol were approved
by the Institutional Animal Care and Use Committee (IACUC)
at Taipei Medical University (certificate no. LAC-101-0300).
The rabbits were maintained according to the regulations of
the IACUC at our institution, where they were housed. All
experiments were performed in accordance with the replace,
reduce, and refine principles outlined in the IACUC guide-
lines. The number of animals was the minimum required to
obtain statistically valid results. The sample size per group
was calculated based on an estimated between-group differ-
ence of 0.5, assuming a two-sided confidence interval of 95%
and a variance of 0.5.
PRF was prepared using the protocol that was described
for the first time internationally by Dohan et al. in 2006 (26)
with slight modifications to improve reproducibility. Because
only rabbits above 3 kg body-weight have large enough ear
veins for venipuncture, these larger rabbits were placed in a
restraining device to facilitate the drawing of blood (Figure 1a).
In addition, xylene (ACS reagent, J. T. Baker, Phillipsburg,
NJ, USA) was applied to the skin over the ear vein to dilate
the vessel and assist in locating the vein. Five millilitres of
blood were drawn from the ear vein (Figure 1b) with a no. 21
gauge butterfly needle, immediately transferred to an 8-mL
sterile plastic tube (without anticoagulant, Vacuettes tube,
2 mL Z no additive, item no. 455071), and centrifuged at
3000 rpm for 10 min in a DSC-200A-2 tabletop centrifuge
(Digisystem, Laboratory Instruments Inc., Taipei, Taiwan). It
is noteworthy that only the venous blood could successfully
produce the PRF gel after it was subject to centrifugation
(Figure 1b-c, confirmation that blood was drawn from the
rabbit auricular vein, not from the central ear artery). A pair
of forceps was used to remove the middle layer (the whole
PRF gel, Figure 1d) from the top layer (plasma) and bottom
layer (RBC). The plasma was then harvested and stored
in an Eppendorf tube (Avants microcentrifuge tube, 1.7 mL,
certified free of RNase/DNase, human DNA, Pyrogen, PCR
inhibitors) for the following analyses. A representative PRF
gel prepared from centrifugation of 5 mL of whole blood
is shown in Figure 1d. Before placing the PRF sample in
the freezer, the surface adsorbing RBC layer fluid had to be
completely drained away to avoid interference with the
cytokine determination assays. The PRF (a pale yellow elastic
gel-like strip) was frozen at  20oC for 30 min and then
transferred to another freezer at  80oC for storage until the
cytokines were quantified. This gradual freezing protocol
mimics the protocol for freezing cells to avoid denaturation
of cytokine proteins as cytokine levels can be decreased by
improper handling and storage of samples (27).
Each of the six PRF samples was divided into three seg-
ments for cytokine quantification. Normally, the pointed tip
on the RBC end was trimmed off, as RBC contamination strongly
influenced cytokine determination using the spectrometer.
Therefore, cytokines from the RBC layer were excluded. Then,
cytokine activation was conducted in 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES, X99.5%, Sigma-Aldrich,
St Louis, MO, USA, pH 7.2-7.6). Cytokine concentration was
measured using sandwich-type ELISA kits (nos. MBS165883,
MBS165545, and MBS704445, MyBiosource, Inc., San Diego,
CA, USA) according to the manufacturer’s instructions. After
the exudate was removed from the defrosted PRF gel,
the remaining white PRF matrix was fixed in 10% forma-
lin (Sigma-Aldrich) for 22 h and dehydrated in a graded
ethanol series (70% to 100%) for the following preparation of
histological specimens.
Histological and scanning electron microscopic
analysis
The PRF sample was fixed, dehydrated and placed in a
tissue cassette and embedded in paraffin wax. Infiltration
of paraffin into the porous tissue maintains the intrinsic mor-
phology of the tissue and solidifies the sample to allow fine
sectioning. The sample was divided into seven segments
(Figure 2a-c), then cut into 3–5 mm sections for histological
analyses. The RBC end and plasma end of the PRF were
similar and easily confused during this preparation of histol-
ogical samples. Sample orientation errors were avoided
by labelling. The tissue sections were mounted on slides,
stained with haematoxylin-eosin or Masson’s trichrome
stain, viewed and photographed under an optical micro-
scope (28). The compactness of the fibrin network (i.e.,
porosity, [n]) was measured directly by scanning electron
microscopy (SEM) using ImageJ software (NIH, Bethesda,
MD, USA). Porosity [n]=Ap/At  %, where Ap denotes the
measured total area of the pores in each SEM image and At is
the total area of an SEM image.
All protocols of histological and SEM analyses for the
animal rabbit model were developed for this PRF sample
and were slightly modified from the typical tissue preparation
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method for light microscopy. Optical microscopy and SEM
were used in a complementary fashion, as they have dif-
ferent levels of resolution for inspecting the fibrin micro-
structure (the resolution of the optical microscope falls
within the mm range and that of the SEM can be in nm). To
prevent charge accumulation and damage to tissue sections
during SEM examination, approximately 80 Å of platinum
was deposited on the tissue sections using a sputter coater.
SEM images were acquired using a field-emission scanning
electron microscope (FESEM, Model JSM-5600, JEOL, Tokyo,
Japan) operated at an accelerating voltage of 15 kV. Serial
images were aligned sequentially in three-dimensional space
and visualized three-dimensionally with Fiji and TrakEM2
software (29,30). In a typical procedure, serial slides can
be manually aligned by setting up a number of pairs of
corresponding control points to the same (x, y) location for
consecutive images zi and zi+1, and the pairs of images and
paired-sets of control points are then given to semi-automatic
software for image alignment. Fully automatic registration
of biological images is then possible as demonstrated by the
software - TrakEM2 (29,30). The average diameters of the
fibrin fibres were obtained by averaging diameters directly
measured in the SEM images of B30 samples.
Statistical analysis
The concentrations of cytokines from six rabbits are expres-
sed as the mean ± SD for each type of cytokine. Student’s
t-test was used to compare results for PRF and plasma (the
control). Po0.05 was considered statistically significant.
Excels (Microsoft, Seattle, WA, USA) was used for statistical
analysis.
’ RESULTS
Cytokine measurement
Figure 3 shows data obtained from all six rabbits. PDGF-BB
and TGF-b1 formed quasi-gradients of concentration from
high at the RBC end (PRF1, p=1.88 10-5 compared with the
level in plasma) to low at the plasma end (PRF3, p=0.19).
IGF-1 concentrations were similar at the RBC and plasma
ends (no statistical significance was observed).
Histological and SEM observations
Compactness and porosity in the PRF tended to be non-
uniform (Figure 4). The fibrin network (see the red area
indicated by the green arrowheads) closest to the RBC layer
had particularly small pores and an ultra-compact structure
Figure 1 - Preparation of platelet-rich fibrin (PRF) gel using blood from New Zealand rabbits. (A) A rabbit is placed in a restraining
frame. (B) Blood is drawn from an ear vein. (C) A 5-mL blood sample is separated into three layers by centrifugation at 3000 rpm for
10 min. (D) A PRF gel forms between the plasma layer (top) and the red blood cell (RBC) layer (bottom).
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with many incorporated platelets (see the blue spots indi-
cated by the white arrowheads, the PRF section observed
in Figure 4a corresponds to PRF1 shown in Figure 3) and
that closest to the plasma layer had larger pores and a less
compact structure (the PRF section observed in Figure 4e
corresponds to PRF3 shown in Figure 3, the remaining images,
i.e., Figure 4b-d, correspond to PRF2 shown in Figure 3). The
porosities of these PRF samples taken in sequence from the
RBC end to the plasma end were 6.5%± 4.9%, 24.8%± 7.5%,
30.3%± 8.5%, 41.4% ± 12.3%, and 40.3% ± 11.7% (Figure 5,
as illustration of sample sites shown in Figure 6a), indicating a
gradual decrease in the compactness of the PRF network.
SEM images showed that the fibrin fibres in the five seg-
ments of a representative PRF sample (images taken seq-
uentially from the RBC end to the plasma end; Figure 6a)
had average diameters of 116 ± 37, 116 ± 39, 123 ± 37,
124 ±38, and 140 ± 39 nm, respectively. In addition,
because robust and fully automatic 3D registration of serial-
section microscopic images is critical for detailed anatomical
reconstruction of large biological specimens, such as the case
of PRF histology shown above. This construction image can
help with providing more information about the essence
of platelet-rich fibrin (ePRF) to gain new structural insights.
On reconstructing the two-dimensional SEM images and
viewing from above, the three-dimensional reconstruction
image of the fibrin matrix was dense and similar in appear-
ance to medical gauze (Figure 7a). From the side-view,
the compactness decreased and porosity increased along the
longitudinal axis of the PRF sample from the RBC end to the
plasma end (Figure 7b).
’ DISCUSSION
This study confirms that platelet cytokines are indeed trap-
ped in PRF gel but contradicts the hypothesis of Mosesson
et al. (31,32) that the trapped platelet cytokines are evenly
distributed throughout the fibrin network. The formation of
a three-dimensional fibrin network resulted in the incorpora-
tion of cytokines into its mesh architecture. We propose that
fibrinogen and thrombin concentrations are higher at the
RBC end of a PRF sample, possibly because of the force of
centrifugation. Our results agree with those of Ryan and
Wang (33, 34), who demonstrated that a higher concentration
of thrombin results in the generation of fibrin with a smaller
diameter and that these smaller fibrin fibres tend to pack
more tightly, such that the porosity is lower. Our results
provide clinically useful information that could support the
development of improved therapeutic interventions, as the
potential curative effect of PRF arises mainly from its high
concentration of incorporated cytokines.
Figure 2 - Photographs showing (A) a defrosted PRF gel, (B) a PRF gel fixed in 10% formalin for 22 h, and (C) the fixed PRF gel
embedded in paraffin, divided into 7 segments and sent for paraffin sectioning. The two ends of the PRF gel were discarded due to
distortion.
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Figure 3 - Cytokine quantification assay of (A) PDGF-BB, (B) TGF-b1, and (C) IGF-1 in PRF gel. All values are expressed as the mean± SD.
The RBC end, middle segment, and plasma end of the PRF clot are labelled PRF1, PRF2, and PRF3, respectively. AVG is the average of the
PRF1, PRF2 and PRF3 values. Concentrations of PDGF-BB and TGF-b1 in PRF1 were always two to five times that in PRF3, but the con-
centration of IGF-1 in PRF1 did not differ significantly from that in PRF3. p valueo0.01 is labelled **, and p valueo0.001 is labelled ***.
All statistical results are with respect to the group of plasma.
Figure 4 - The five segments obtained from the PRF sample shown in Figure 2 were used for histological analysis, and sections were
stained with Masson’s trichrome. Sections from the RBC end (A), middle segment (B-D), and plasma end (E) of the PRF show a decrease
in compactness and increase in porosity as the view of the PRF gel shifts from the RBC end to the plasma end. A micrograph (F) taken at
high magnification from (A), revealing finer structural details.
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Images of histologically stained PRF show fibrin networks
with varying degrees of compactness. To the best of our knowl-
edge, the three-dimensional fibrin network of leukocyte-PRF
(L-PRF) first reported by Dohan et al. in 2006 is the catalyst
for the incorporation of cytokines into the mesh architecture.
However, this idea is based on theoretical computer model-
ling of a PRF clot, not empirical evidence. Our three-dimensional
representation of the PRF microstructure reconstructed from
a series of two-dimensional SEM images shows a dense fibrin
matrix with surface morphology similar to that of medical
gauze. This tangled fibrous architecture, in contrast to the
architecture of the first-generation platelet concentrate commonly
known as PRP, is responsible for the slower release of growth
factors and the entrapment of more platelets inside the gel
(21,35). Our findings suggest that the gradient distribution
of cytokines in PRF gel is strongly related to its three-
dimensional structure, especially the porosity and compact-
ness of the fibrin network. Although this structure-cytokine
gradient relationship seems tied to the conditions of PRF
preparation, such as types of tube for collecting blood, types
of centrifuge, centrifugal force and duration of centrifugation
(36), it has not been possible to establish this relationship by
conducting systematic empirical investigation because of the
narrow window for successful in vivo preparation of PRF
when the L-PRF technique was applied to an animal (rabbit)
model. However, in vitro, Ryan and Wang (33,34) have
shown that adding higher concentrations of thrombin results
in the generation of fibrin with a smaller diameter.
When a whole blood sample is centrifuged, a gelled mem-
brane (the buffy coat layer) forms between the RBC layer and
the plasma layer. The buffy coat contains most of the platelets,
which are activated during centrifugation. The surface of
these activated platelets is known to contain glycoprotein
IIb/IIIa, which is a receptor for binding the soluble fibrino-
gen protein in fluid (37). The activated platelets also stimu-
late the formation of thrombin and induce the subsequent
polymerisation of fibrinogen to form fibrin molecules. These
adhere to one another and then become assembled into long
fibrils. The formation of this fibrin gel is generally deter-
mined by the balance between the lateral aggregation of
fibrinogen monomers and the rate of fibrinopeptide cleavage (38).
At a high concentration of thrombin, the rate of fibrinopep-
tide cleavage, with simultaneous creation of many branch-
points, exceeds the rate of lateral aggregation of fibrinogen
monomers, giving rise to a network of thin fibres. Therefore,
we propose that the concentration of fibrinogen and thrombin
at the RBC end of the PRF gel is higher than that in the rest of
the PRF, possibly because of the effects of density-gradient
centrifugation and incorporation of platelets (Figure 4a). This
provides a microenvironment conducive to the formation of
a network composed of small but densely packed fibres. Our
results (Figures 4–7) confirmed that the fibrin fibres at the
RBC end of the PRF clot were more tightly packed (of higher
density and smaller diameter) and therefore had lower porosity,
so the fibres trapped more platelets, which exhibited a lock-
ing effect on the cytokines and thrombin. Conversely, the
thrombin components required for conversion of fibrinogen
to fibrin pass through the densely packed fibrin network
from the RBC end to the plasma end of the PRF gel, gener-
ating a loosely packed fibrin network at the plasma end.
The distributions of PDGF-BB and TGF-b1, but not IGF-1,
in the PRF gel were quasi-graded, and their concentrations
were much higher in the PRF gel than in the plasma. Our
preliminary results indicated that this effect is a combination
of two factors: 1) an extrinsic factor attributed to the fibrin gel
structure; and 2) an intrinsic factor attributed to the molec-
ular structure of different cytokines. All of these cytokines
were soluble and therefore should concentrate in plasma
after centrifugation. However, the highest concentrations of
the cytokines were at the RBC end of the gel, implying that
the cytokines were stoichiometrically trapped in the PRF gel.
This was a process akin to harvesting fish by casting a net
Figure 5 - Statistics concerning the porosity of the PRF specimens shown in Figure 2 (for interpretation of the sample labelling, please
refer to Figure 6a).
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into water; the process depended on the size of the mesh,
which if small could remove more large granules or molec-
ules, such as platelets, PDGF-BB (31 kDa) (39), and TGF-b1
(25 kDa) (40). Because of its much lower molecular weight,
IGF-1 (7 kDa) was less likely to be incorporated and retained
in the fibrin matrix (41), which is consistent with the obser-
vation of Dohan et al. that IGF-1 is principally a circulating
molecule (13), tending to concentrate in the upper part of the
tube after centrifugation. We believe that this determina-
tion of the cytokine content of PRF produced from L-PRF
technique applied to rabbit model and its relationship with
the three-dimensional fibrin network structure will have a
positive impact on the development of PRF products with
higher clinical efficacy, such as surgical implantation of PRF
in repairing articular cartilage or implanting a tooth (42) as
patients desire a smaller incision, faster identification of the
defect, and fewer surgeries.
In conclusion, the concentration of cytokines in a PRF gel is
not uniform. The RBC end of a PRF gel contains the highest
concentration of platelets and cytokines, which was thus
defined as the essence of platelet-rich fibrin (ePRF). Three
factors govern this distribution of cytokines: 1) the platelet
distribution (which determines the concentration of throm-
bin); 2) the three-dimensional fibrin structure (which differs
in porosity and compactness); and 3) the molecular weights
of the cytokines. The structure of the PRF gel and its related
cytokine distribution can inform the decision to use PRF clini-
cally, as the efficacy of PRF is theoretically mainly dependent
on the high concentrations of growth factors found within
PRF compared with whole blood, which is similar to other
platelet-rich products. A more extensive animal study and
institutional review board (IRB)-approved human-subject
study is currently comparing and extrapolating the findings
of our work.
Figure 6 - (A) Diagrammatic view of a sectioned PRF gel and (B–F) SEM images of the series of PRF sections shown in Figure 2. Labels in
(A) indicate the five segments of the PRF sample observed in the SEM micrographs.
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